-
Mashup Score: 1Health Canada Slated to Review New Drug Submission for Momelotinib in Myelofibrosis - 3 month(s) ago
Health Canada will review the new drug submission seeking the approval of momelotinib in patients with myelofibrosis.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1Health Canada Slated to Review New Drug Submission for Momelotinib in Myelofibrosis - 3 month(s) ago
Health Canada will review the new drug submission seeking the approval of momelotinib in patients with myelofibrosis.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet-
Health Canada Slated to Review New Drug Submission for Momelotinib in Myelofibrosis #oncology #hematology https://t.co/iKQJrkBpIn
-
-
Mashup Score: 1Health Canada Slated to Review New Drug Submission for Momelotinib in Myelofibrosis - 3 month(s) ago
Health Canada will review the new drug submission seeking the approval of momelotinib in patients with myelofibrosis.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet-
Health Canada Slated to Review New Drug Submission for Momelotinib in Myelofibrosis #oncology #hematology https://t.co/iKQJrkBpIn
-
-
Mashup Score: 3In the U.S., scientists see barriers to the development of CAR-T cell therapies. In Spain, a hospital brews its own - 5 month(s) ago
A special European policy allows researchers at hospitals to make their own advanced cell or gene therapies under particular circumstances and earn some form of regulatory approval.
Source: www.statnews.comCategories: General Medicine News, Future of MedicineTweet-
Fascinating. What keeps others from adopting this approach? Would love to hear more from @juliodelgadohem on this!! In the U.S., scientists see barriers to the development of CAR-T cell therapies. In Spain, a hospital brews its own https://t.co/7aOmWZnZwa #Oncology #Hematology https://t.co/UrbdpijrfR
-
-
Mashup Score: 0
Uwe Platzbecker, MD, discusses how to navigate decisions for the first-line treatment of anemia in patients with lower-risk MDS in light of luspatercept’s approval, expands on key data from the COMMANDS trial, and addresses potential concerns from clinicians who are uncertain about when to utilize this agent in the frontline setting in clinical practice.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet-
Luspatercept Approval Shifts Treatment Landscape of Anemia in Lower-Risk MDS @UwePlatzbecker #oncology #hematology https://t.co/z3UvhwgrsT
-
-
Mashup Score: 0
Uwe Platzbecker, MD, discusses how to navigate decisions for the first-line treatment of anemia in patients with lower-risk MDS in light of luspatercept’s approval, expands on key data from the COMMANDS trial, and addresses potential concerns from clinicians who are uncertain about when to utilize this agent in the frontline setting in clinical practice.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet-
Luspatercept Approval Shifts Treatment Landscape of Anemia in Lower-Risk MDS @UwePlatzbecker #oncology #hematology https://t.co/z3UvhwgrsT
-
-
Mashup Score: 1Making the decision each day to stay in clinical medicine - 2 year(s) ago
I have chosen to stay. But I will stay empowered. I realize it is my decision. Right now, I grieve the fact that each day I have to make the decision to stay. To stay in what was once a dream of mine. Health care is no longer what it once was. Where are we heading? What is the future? Today I am celebrating that I once again decided to stay—another sticker. Hopefully, one day I will no longer…
Source: KevinMD.comCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @kevinmd: Making the decision each day to stay in clinical medicine https://t.co/gUSmf5wiDM #Physician #OncologyHematology via @kevinmd
-
-
Mashup Score: 0Above The Fold in Healthcare - 2 year(s) ago
The Front Page of Healthcare News on the Internet by C. Michael Gibson MD
Source: paper.liCategories: Expert Picks, Latest HeadlinesTweet-
The latest Above The Fold in Healthcare! https://t.co/945IZcIRvv Thanks to @Reuters_Health @NEJM @kevinmd #physician #oncologyhematology
-
-
Mashup Score: 2
Doctors are unique in that our knowledge and experience are incredibly valuable, but distributed scarcely via single episode live events. When we convert our knowledge into digital assets that can be consumed at scale, we earn time, efficiency and carve space to do only the things we can do.
Source: KevinMD.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
RT @kevinmd: How to convert medical knowledge into digital assets that work for you https://t.co/Q8fZ1442iz #Physician #OncologyHematology…
-
-
Mashup Score: 0Above The Fold in Healthcare - 3 year(s) ago
The Front Page of Healthcare News on the Internet by C. Michael Gibson MD
Source: paper.liCategories: Cardiologists, Latest HeadlinesTweet-
The latest Above The Fold in Healthcare! https://t.co/R3DgMlSAGD Thanks to @medpagetoday @Reuters_Health @kevinmd #podcast #oncologyhematology
-
Health Canada Slated to Review New Drug Submission for Momelotinib in Myelofibrosis #oncology #hematology https://t.co/iKQJrkBpIn